{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T03:40:32Z","timestamp":1775706032342,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.anai.2021.04.040","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:21:46Z","timestamp":1620944506000},"page":"261-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Shortened desensitization leading to a 2-year enzyme replacement therapy with elosulfase alfa"],"prefix":"10.1016","volume":"127","author":[{"given":"Hayrunnisa","family":"Bekis Bozkurt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuba","family":"Karakurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Cavkaytar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Arga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2021.04.040_bib0001","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13023-014-0173-x","article-title":"A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases","volume":"9","author":"Leadley","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.anai.2021.04.040_bib0002","unstructured":"BioMarin Pharmaceutical Inc. Vimizim. Full prescribing information. Available at: https:\/\/www.vimizim.com\/wp-content\/uploads\/2018\/02\/Prescribing-Information.pdf. Accessed January 3, 2021."},{"issue":"11","key":"10.1016\/j.anai.2021.04.040_bib0003","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1398-9995.2010.02441.x","article-title":"General considerations on rapid desensitization for drug hypersensitivity\u2014a consensus statement","volume":"65","author":"Cernadas","year":"2010","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.anai.2021.04.040_bib0004","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs\u2014an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.anai.2021.04.040_bib0005","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.anai.2020.07.010","article-title":"Management of hypersensitivity reactions to enzyme replacement therapy in children with lysosomal storage diseases","volume":"125","author":"Turgay Yagmur","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.anai.2021.04.040_bib0006","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ymgme.2018.02.011","article-title":"Safety, immunogenicity, and clinical outcomes in patients with Morquio A syndrome participating in 2 sequential open-label studies of elosulfase alfa enzyme replacement therapy (MOR-002\/MOR-100), representing 5 years of treatment","volume":"123","author":"Hendriksz","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.1016\/j.anai.2021.04.040_bib0007","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jaip.2017.02.020","article-title":"Successful desensitization of elosulfase alfa-induced anaphylaxis in a pediatric patient with Morquio syndrome","volume":"5","author":"Guvenir","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.anai.2021.04.040_bib0008","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/pai.13049","article-title":"Anaphylaxis after elosulfase A infusion: omalizumab as coadjuvant for enzyme replacement therapy desensitization","volume":"30","author":"Arroabarren","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"10.1016\/j.anai.2021.04.040_bib0009","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/anae.14963","article-title":"Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK","volume":"75","author":"Woodcock","year":"2020","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.anai.2021.04.040_bib0010","first-page":"30","article-title":"Case series of sebelipase alfa hypersensitivity reactions and successful sebelipase alfa rapid desensitization","volume":"49","author":"Huffaker","year":"2019","journal-title":"JIMD Rep"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112062100332X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112062100332X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:26:32Z","timestamp":1761053192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108112062100332X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S108112062100332X"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2021.04.040","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shortened desensitization leading to a 2-year enzyme replacement therapy with elosulfase alfa","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2021.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}